These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11181748)

  • 1. Mechanisms for cholesterol homeostasis in rat jejunal mucosa: effects of cholesterol, sitosterol, and lovastatin.
    Nguyen LB; Shefer S; Salen G; Tint GS; Ruiz F; Bullock J
    J Lipid Res; 2001 Feb; 42(2):195-200. PubMed ID: 11181748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in the rat ileum: effects of bile acids and lovastatin.
    Nguyen LB; Shefer S; Salen G; Ness GC; Batta A; Chowdhary IR; Paroulek E; Hauser S
    Metabolism; 1994 Nov; 43(11):1446-50. PubMed ID: 7968602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of early cholesterol biosynthesis in rat liver: effects of sterols, bile acids, lovastatin, and BM 15.766 on 3-hydroxy-3-methylglutaryl coenzyme A synthase and acetoacetyl coenzyme A thiolase activities.
    Honda A; Salen G; Nguyen LB; Xu G; Tint GS; Batta AK; Shefer S
    Hepatology; 1998 Jan; 27(1):154-9. PubMed ID: 9425931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficient ileal 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in sitosterolemia: sitosterol is not a feedback inhibitor of intestinal cholesterol biosynthesis.
    Nguyen LB; Salen G; Shefer S; Bullock J; Chen T; Tint GS; Chowdhary IR; Lerner S
    Metabolism; 1994 Jul; 43(7):855-9. PubMed ID: 8028508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage 3-hydroxy-3-methylglutaryl coenzyme a reductase activity in sitosterolemia: effects of increased cellular cholesterol and sitosterol concentrations.
    Nguyen LB; Salen G; Shefer S; Tint GS; Ruiz F
    Metabolism; 2001 Oct; 50(10):1224-9. PubMed ID: 11586498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in serum and bile cholesterol and HMG-CoA reductase by lovastatin in rats.
    Yamauchi S; Linscheer WG; Beach DH
    Am J Physiol; 1991 Apr; 260(4 Pt 1):G625-30. PubMed ID: 2018137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal regulation of the LDL-R and HMG CoA reductase genes in subjects with familial hypercholesterolemia with the "French Canadian mutation".
    Yu L; Qiu S; Genest J
    Atherosclerosis; 1996 Jul; 124(1):103-17. PubMed ID: 8800498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sterol synthesis. Synthesis of 3 beta-hydroxy-25,26,26,26,27,27,27-heptafluorocholest-5-en-7-one and its effects on HMG-CoA reductase activity in Chinese hamster ovary cells, on ACAT activity in rat jejunal microsomes, and serum cholesterol levels in rats.
    Carroll JN; Pinkerton FD; Su X; Gerst N; Wilson WK; Schroepfer GJ
    Chem Phys Lipids; 1998 Aug; 94(2):209-25. PubMed ID: 9779586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 15-oxa-32-vinyl-lanost-8-ene-3 beta,32 diol on the expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase and low density lipoprotein receptor in rat liver.
    Ness GC; Lopez D; Chambers CM; Zhao Z; Beach DL; Ko SS; Trzaskos JM
    Arch Biochem Biophys; 1998 Sep; 357(2):259-64. PubMed ID: 9735166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase activity is inhibited by cholesterol and up-regulated by sitosterol in sitosterolemic fibroblasts.
    Honda A; Salen G; Honda M; Batta AK; Tint GS; Xu G; Chen TS; Tanaka N; Shefer S
    J Lab Clin Med; 2000 Feb; 135(2):174-9. PubMed ID: 10695663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
    Davis HR; Pula KK; Alton KB; Burrier RE; Watkins RW
    Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective compensatory induction of hepatic HMG-CoA reductase in response to inhibition of cholesterol absorption.
    Ness GC; Holland RC; Lopez D
    Exp Biol Med (Maywood); 2006 May; 231(5):559-65. PubMed ID: 16636304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression by sterols and nonsterols in rat liver.
    Ness GC; Eales S; Lopez D; Zhao Z
    Arch Biochem Biophys; 1994 Feb; 308(2):420-5. PubMed ID: 8109970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of diet and lovastatin on regression of fatty streak lesions and on hepatic and intestinal mRNA levels for the LDL receptor and HMG CoA reductase in F1B hamsters.
    Pitman WA; Osgood DP; Smith D; Schaefer EJ; Ordovas JM
    Atherosclerosis; 1998 May; 138(1):43-52. PubMed ID: 9678770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RG 12561 (dalvastatin): a novel synthetic inhibitor of HMG-CoA reductase and cholesterol-lowering agent.
    Amin D; Gustafson SK; Weinacht JM; Cornell SA; Neuenschwander K; Kosmider B; Scotese AC; Regan JR; Perrone MH
    Pharmacology; 1993; 46(1):13-22. PubMed ID: 8434028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of lifibrol (K12.148) on the cholesterol metabolism of cultured cells: evidence for sterol independent stimulation of the LDL receptor pathway.
    Scharnagl H; Schliack M; Löser R; Nauck M; Gierens H; Jeck N; Wieland H; Gross W; März W
    Atherosclerosis; 2000 Nov; 153(1):69-80. PubMed ID: 11058701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Farnesol is not the nonsterol regulator mediating degradation of HMG-CoA reductase in rat liver.
    Keller RK; Zhao Z; Chambers C; Ness GC
    Arch Biochem Biophys; 1996 Apr; 328(2):324-30. PubMed ID: 8645011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of cholesterol biosynthesis in sitosterolemia: effects of lovastatin, cholestyramine, and dietary sterol restriction.
    Nguyen LB; Cobb M; Shefer S; Salen G; Ness GC; Tint GS
    J Lipid Res; 1991 Dec; 32(12):1941-8. PubMed ID: 1816322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel cholesterol-lowering drug SR-12813 inhibits cholesterol synthesis via an increased degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
    Berkhout TA; Simon HM; Patel DD; Bentzen C; Niesor E; Jackson B; Suckling KE
    J Biol Chem; 1996 Jun; 271(24):14376-82. PubMed ID: 8662919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of HMG-CoA reductase, apoprotein-B and LDL receptor gene expression by the hypocholesterolemic drugs simvastatin and ciprofibrate in Hep G2, human and rat hepatocytes.
    Qin W; Infante J; Wang SR; Infante R
    Biochim Biophys Acta; 1992 Jul; 1127(1):57-66. PubMed ID: 1627634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.